Your browser doesn't support javascript.
loading
Recombinant Thrombomodulin Has Anti-tumor Effects and Enhances the Effects of Gemcitabine for Pancreatic Cancer Through G-protein Coupled Receptor 15.
Furukawa, Kenei; Ling, Jianhua; Sun, Yichen; Lu, Y U; Fu, Jie; Marukuchi, Rui; Chiao, Paul J.
Affiliation
  • Furukawa K; Department of Molecular and Cellular Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX, U.S.A.; k-furukawa@jikei.ac.jp.
  • Ling J; Department of Surgery, The Jikei University School of Medicine, Tokyo, Japan.
  • Sun Y; Department of Molecular and Cellular Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX, U.S.A.
  • Lu YU; Department of Molecular and Cellular Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX, U.S.A.
  • Fu J; Department of Molecular and Cellular Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX, U.S.A.
  • Marukuchi R; Department of Molecular and Cellular Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX, U.S.A.
  • Chiao PJ; Department of Surgery, The Jikei University School of Medicine, Tokyo, Japan.
Anticancer Res ; 42(10): 4679-4687, 2022 Oct.
Article in En | MEDLINE | ID: mdl-36191971
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pancreatic Neoplasms / Carcinoma, Pancreatic Ductal Type of study: Prognostic_studies Limits: Humans Language: En Journal: Anticancer Res Year: 2022 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pancreatic Neoplasms / Carcinoma, Pancreatic Ductal Type of study: Prognostic_studies Limits: Humans Language: En Journal: Anticancer Res Year: 2022 Type: Article